133 related articles for article (PubMed ID: 10518104)
1. Liver fatty acid-binding protein is a new prognostic factor for hepatic resection of colorectal cancer metastases.
Yamazaki T; Kanda T; Sakai Y; Hatakeyama K
J Surg Oncol; 1999 Oct; 72(2):83-7. PubMed ID: 10518104
[TBL] [Abstract][Full Text] [Related]
2. Liver fatty acid binding protein expression in colorectal neoplasia.
Lawrie LC; Dundas SR; Curran S; Murray GI
Br J Cancer; 2004 May; 90(10):1955-60. PubMed ID: 15138477
[TBL] [Abstract][Full Text] [Related]
3. Changes in liver fatty acid-binding protein in rat enzyme-altered foci.
Thullberg M; Grasl-Kraupp B; Högberg J; Garberg P
Cancer Lett; 1998 Jun; 128(1):1-10. PubMed ID: 9652787
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
5. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
Kuijpers AL; Bergers M; Siegenthaler G; Zeeuwen PL; van de Kerkhof PC; Schalkwijk J
Acta Derm Venereol; 1997 Jan; 77(1):14-9. PubMed ID: 9059669
[TBL] [Abstract][Full Text] [Related]
6. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
[TBL] [Abstract][Full Text] [Related]
7. Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer.
Nagashima I; Oka T; Hamada C; Naruse K; Osada T; Muto T
Am J Gastroenterol; 1999 Mar; 94(3):739-43. PubMed ID: 10086660
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
[TBL] [Abstract][Full Text] [Related]
9. Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators?
Wang JY; Chiang JM; Jeng LB; Changchien CR; Chen JS; Hsu KC
Dis Colon Rectum; 1996 Aug; 39(8):847-51. PubMed ID: 8756838
[TBL] [Abstract][Full Text] [Related]
10. Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.
Yamamoto S; Tanaka K; Takeda K; Akiyama H; Ichikawa Y; Nagashima Y; Endo I
Ann Surg Oncol; 2014 Jun; 21(6):1853-61. PubMed ID: 24554065
[TBL] [Abstract][Full Text] [Related]
11. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
[TBL] [Abstract][Full Text] [Related]
12. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?
Weber JC; Nakano H; Bachellier P; Oussoultzoglou E; Inoue K; Shimura H; Wolf P; Chenard-Neu MP; Jaeck D
Am J Surg; 2001 Jul; 182(1):81-8. PubMed ID: 11532423
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical demonstration of liver fatty acid-binding protein in human hepatocellular malignancies.
Suzuki T; Watanabe K; Ono T
J Pathol; 1990 May; 161(1):79-83. PubMed ID: 2164578
[TBL] [Abstract][Full Text] [Related]
14. The time interval between primary colorectal carcinoma resection to occurrence of liver metastases is the most important factor for hepatic resection. Analysis of total course following primary resection of colorectal cancer.
Sato T; Konishi K; Yabushita K; Nojima N; Kimura H; Maeda K; Tsuji M; Miwa A
Int Surg; 1998; 83(4):340-2. PubMed ID: 10096757
[TBL] [Abstract][Full Text] [Related]
15. A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection.
Nagashima I; Takada T; Matsuda K; Adachi M; Nagawa H; Muto T; Okinaga K
J Hepatobiliary Pancreat Surg; 2004; 11(2):79-83. PubMed ID: 15127268
[TBL] [Abstract][Full Text] [Related]
16. Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer.
Onodera H; Mori A; Nagayama S; Fujimoto A; Tachibana T; Yonenaga Y; Tsuruyama T
Int J Colorectal Dis; 2005 Nov; 20(6):477-84. PubMed ID: 15846499
[TBL] [Abstract][Full Text] [Related]
17. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of clinical and pathologic risk factors in liver resection for hepatic colorectal metastases.
Zhou L; Zhag G; Tang T; Lian R; Wang W
J Cancer Res Ther; 2013 Nov; 9 Suppl():S178-82. PubMed ID: 24516057
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
